Where is Chefarma located?

Chefarma is headquartered in Greece.

Is Chefarma a funded company?

Chefarma is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Chefarma rank among its competitors?

Chefarma ranks 4151st amongst 4232 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was EBOS Group, which secured $124M in Apr, 2025.

Who are the top competitors of Chefarma?

Chefarma's top competitors include AmerisourceBergen, Entero Healthcare and EBOS Group. Among them, EBOS Group secured the most recent funding round in April, 2025.

Chefarma - 2026 Company Profile & Competitors

Chefarma is an unfunded company based in Greece. It operates as a Provider of active pharmaceutical ingredients and finished drug formulations. Chefarma has not raised any funding yet. The company has 4232 active competitors, including 27 funded and 231 that have exited. Its top competitors include companies like AmerisourceBergen, Entero Healthcare and EBOS Group.

Company Details

Provider of active pharmaceutical ingredients and finished drug formulations. They offer sourcing and procurement of ingredients, along with business development of formulations. The company facilitates benchmarking against industry standards. It also promotes sales through its network of customers and manufacturers.

Key Metrics

Location

Greece

Stage

Unfunded

Ranked

4151^st among 4232 active competitors

Similar Companies

AmerisourceBergen & 4461 more

View Chefarma's full profile

Chefarma has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Chefarma include AmerisourceBergen, Entero Healthcare and EBOS Group. Here is the list of Top 10 competitors of Chefarma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AmerisourceBergen 1985, Chesterbrook (United States), Public	Drug Corporation	-	nextGENE Capital, Walgreens Boots Alliance ... & 4 others	71/100
2nd	Entero Healthcare 2018, Mumbai (India), Public	Operator of an integrated healthcare products distribution platform	$59.7M	Orbimed, Millennium Medicare & 38 others	66/100
3rd	EBOS Group 1922, Docklands (Australia), Public	Wholesaler & distributor of healthcare, medical, and pharmaceutical products	-	-	61/100
4th	Keimed 2000, Hyderabad (India), Series B	Pharmaceutical distributor of temperature-sensitive medicines	$16.6M	Mitsui, Apollo Hospitals & 2 others	59/100
5th	Cencora 2001, Conshohocken (United States), Public	Provider of clinical trial logistics and other biopharma outsourcing services	-	-	57/100
6th	CHEPLAPHARM 1998, Mesekenhagen (Germany), Late Stage	Pharmaceutical company that specializes in the development, marketing, and distribution of branded pharmaceutical products	$547M	GIC, Atlantic Park & 4 others	52/100
7th	Target Healthcare 2012, East Kilbride (United Kingdom), Series B	Distributor of pharmaceutical products	$26.1M	Santander	51/100
8th	Dizal Pharma 2017, Pudong (China), Series A	Limited information available	$100M	Lilly Asia Ventures, HongShan & 3 others	49/100
9th	Wellgistics Health 2022, Tampa (United States), Public	Provider of pharmaceutical logistics and technology solutions for prescription fulfillment	-	-	48/100
10th	PHOENIX group 1994, Frankfurt Am Main (Germany), Unfunded	Diversified pharmaceutical distributor	-	-	48/100
4151st	Chefarma Greece, Unfunded	Provider of active pharmaceutical ingredients and finished drug formulations	-	-	16/100